Document Detail

Sotalol exhibits reverse use-dependent action on monophasic action potentials in normal but not in infarcted canine ventricular myocardium.
MedLine Citation:
PMID:  1380589     Owner:  NLM     Status:  MEDLINE    
In 12 anesthetized mongrel dogs (30 mg/kg pentobarbital), a thoracotomy was performed, and the left anterior descending coronary artery was ligated proximally. Eight to 12 days later, monophasic action potentials were recorded endocardially from the apex of the noninfarcted right ventricle and infarcted areas of the left ventricle, and the effects of 1.5 mg/kg intravenous sotalol were evaluated. Monophasic action potentials from the infarcted zone of the left ventricle were obtained from areas where fractionated bipolar electrograms could be recorded; this was histologically confirmed. After sotalol, in sinus rhythm, the monophasic action potential duration at 90% repolarization of the infarcted zone increased from 186 +/- 31 to 226 +/- 45 ms (+ 22%, p less than 0.05), and monophasic action potential duration of the noninfarcted zone increased from 184 +/- 31 to 225 +/- 47 ms (+ 22%, p less than 0.05). Programmed ventricular stimulation was performed with single extrastimuli at a basic drive cycle length of 300 ms. With long coupling intervals (290 ms), monophasic action potential duration of the infarcted zone increased from 165 +/- 23 to 183 +/- 25 ms (+ 11%, p less than 0.05) after sotalol; and monophasic action potential duration of the noninfarcted zone increased from 159 +/- 20 to 180 +/- 25 ms (+ 13%, p less than 0.05). With short coupling intervals (200 ms), the monophasic action potential duration of the noninfarcted zone increased from 157 +/- 19 to 173 +/- 18 ms (+ 10%, p less than 0.05), and monophasic action potential duration of the noninfarcted zone increased from 150 +/- 18 to 157 +/- 18 ms (+ 5%, NS).(ABSTRACT TRUNCATED AT 250 WORDS)
C Schmitt; T Beyer; M Karch; M Montero; T Hilbel; J Brachmann; W Kübler
Related Documents :
18019519 - Preventing torsades de pointes by careful cardiac monitoring in hospital settings.
16226079 - Short qt syndrome. genotype-phenotype correlations.
9391289 - Qt dispersion as a risk factor for sudden cardiac death and fatal myocardial infarction...
20667549 - How the knowledge of genetic "makeup" and cellular data can affect the analysis of repo...
1576089 - Heart rate--qt relationships during baroreceptor stimulation with diminished autonomic ...
9255689 - High-rate atrial pacing as an innovative bridging therapy in a neonate with congenital ...
24785889 - Arrhythmogenic right ventricular cardiomyopathy in a 20-year-old woman with systemic sc...
3597989 - Arrhythmias before and after anatomic correction of transposition of the great arteries.
22695389 - The effect of revascularization procedures on myocardial infarction incidence rates and...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  19     ISSN:  0160-2446     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:  1992 Apr 
Date Detail:
Created Date:  1992-09-18     Completed Date:  1992-09-18     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  487-92     Citation Subset:  IM    
Department of Cardiology, University of Heidelberg, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Action Potentials / drug effects
Heart / drug effects*,  physiology,  physiopathology
Heart Conduction System / drug effects*
Myocardial Infarction / physiopathology*
Sotalol / pharmacology*
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Combination of nifedipine and doxazosin in essential hypertension.
Next Document:  d-Sotalol has opposite effects from encainide and propafenone on the proportion of episodes of ventr...